Alzheimer’s drug, the monoclonal antibody lecanemab, slowed decline in a phase 3 clinical trial, the company said.
admin, , HEALTH & FITNESS, 0
Related Articles
NIH Director Jay Bhattacharya will take over leadership of CDC temporarily
Dr. Jay Bhattacharya, who directs the National Institute of Health, is taking over as acting director of the Centers...
Measles infections pose far more risks than most realize, including a fatal neurological complication
Erica Finkelstein-Parker planned her daughter’s 8th birthday party with love. Because Emmalee adored airplanes, Finkelstein-Parker chose the theme “Flying...
Abortion is now decriminalized in 12 Mexican states
MEXICO CITY — Mexico’s Supreme Court said this week that it had decriminalized abortion in the central state of...
States are rolling out vaccination plans. Track the numbers inoculated across the country.
Two vaccines to prevent Covid-19 infections have now been granted authorization for emergency use, and every day thousands more...
Black women are more likely than white women to die of all types of breast cancer
Black women are more likely than white women to die from even the most treatable types of breast cancer,...
Florida has more new Covid cases than ever before
ORLANDO, Fla. — Florida reported 21,683 new cases of Covid-19, the state’s highest one-day total since the start of...
Covid testing company with 300 pop-up sites across U.S. under state and federal investigation
A company that operates more than 300 Covid-19 pop-up testing sites around the country is under investigation in multiple...
Stress eating doesn’t always mean craving more: What to know to avoid overeating
Many Americans are really stressed out right now. When we’re emotionally overwhelmed, it probably feels natural to reach for...
